Related Experiment Videos
Combined hepatocellular and cholangiocellular carcinoma
1Department of Radiology, Osaka University Medical School, Japan.
Radiation Medicine
|July 1, 1997
Summary
This study retrospectively analyzed a patient with combined hepatocellular carcinoma (HCC) and cholangiocellular carcinoma (CCC), correlating pathological and radiological findings. Differentiating HCC and CCC components based on vascularity on imaging is key for diagnosis.
Area of Science:
- Hepatobiliary imaging
- Oncology
- Radiology
Background:
- Combined hepatocellular carcinoma (HCC) and cholangiocellular carcinoma (CCC) is a rare liver malignancy.
- Accurate preoperative diagnosis is crucial for appropriate treatment planning.
Observation:
- A patient with combined HCC and CCC underwent partial hepatectomy.
- Radiological findings on CT and MRI were correlated with pathological results.
Findings:
- The tumor exhibited hypoattenuation and hypoenhancement on CT.
- MRI revealed heterogeneous signal intensities on T1- and T2-weighted images.
- Distinct enhancement patterns were observed: HCC component showed hyperenhancement in the arterial phase, while the CCC component showed hypoenhancement.
Implications:
- Radiological imaging, particularly dynamic MRI, can help differentiate between HCC and CCC components in mixed tumors.
- Identifying varying vascularity within a hepatic tumor suggests a combined HCC and CCC diagnosis.
- This correlation aids in surgical planning and patient management for rare liver cancers.